辉瑞和Moderna拒绝了白宫“疫苗峰会”的邀请

据消息人士透露，Covid-19疫苗制造商 辉瑞和Moderna都拒绝了特朗普总统周二白宫“疫苗峰会”的邀请。这两家可能在未来几周内获得Covid-19疫苗紧急授权。

疫苗制造商缺席“疫苗峰会”，这个话题确实很引人注目。当此消息在上周被首次报道时，很多人认为这就是一个公关噱头。

其实，就算是噱头也好，另一方面这也是美国政府向食品和药物管理局（FDA）施压的表现，要求其迅速批准。据Axios和Bloomberg报道，美国食品药品监督管理局局长Stephen Hahn两次被请到白宫，解释为什么FDA为辉瑞（Pfizer）和摩登纳（Moderna）疫苗发放紧急使用授权的时间表比预期的要慢。

其他参与疫苗配送物流，但不涉及疫苗研发的公司，仍有可能参加；包括联邦快递、UPS、CVS、Walgreens和McKesson。不过，据熟悉活动策划的消息人士透露，许多公司可能会派出级别较低的高管，而不是首席执行官。

Both Pfizer and Moderna, the two major drug manufacturers likely to receive emergency authorizations for a Covid-19 vaccine in the coming weeks, have rejected invitations from President Trump to appear at a White House “Vaccine Summit” on Tuesday, according to two sources familiar with the event’s planning.

The vaccine manufacturers’ absences will be conspicuous at a “Vaccine Summit,” an event that drug industry figures and one Trump administration official largely viewed as a public relations stunt when STAT first reported the event last week.

The event appeared to be an effort for the administration to claim credit for the rapid development of a Covid-19 vaccine and to pressure the Food and Drug Administration to move quickly on an authorization. The agency’s commissioner, Stephen Hahn, was twice called to the White House to explain the FDA’s slower-than-desired timetable for issuing emergency use authorizations for Pfizer and Moderna’s vaccines, Axios and Bloomberg reported.

Other companies involved in vaccine distribution logistics, but not in vaccine development itself, are still likely to attend, including FedEx, UPS, CVS, Walgreens, and McKesson. Many, however, are likely to send lower-ranking executives as opposed to their CEOs, according to the sources familiar with the event’s planning.  source

指尖新闻：高信噪比，一目了然

新冠疫情追踪